Levocetirizin 1 A Pharma (Levocetirizine Dihydrochloride)

Levocetirizine is a second‑generation H1‑antagonist used to manage allergic conditions by blocking peripheral histamine receptors.

• Allergic rhinitis: reduces nasal congestion, itching and sneezing caused by seasonal or perennial allergens.
• Chronic idiopathic urticaria: alleviates hives and itching associated with persistent spontaneous urticaria.
• Seasonal allergic conjunctivitis: helps control eye itching and redness linked to allergen exposure.

• Levocetirizine selectively binds to peripheral H1‑histamine receptors, preventing histamine from triggering the cascade that leads to vasodilation, increased vascular permeability, and sensory nerve activation. By blocking this receptor, it reduces the typical signs of allergic inflammation without readily crossing the blood‑brain barrier, thereby minimizing central nervous system effects.

Levocetirizine is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects

• Headache: mild to moderate pain often reported during early treatment.
• Dry mouth: sensation of reduced salivation.
• Fatigue: transient drowsiness or reduced energy.
• Nausea: mild stomach upset.

Serious or Rare Side Effects

• Anaphylaxis: severe, potentially life‑threatening allergic reaction requiring immediate medical attention.
• Stevens‑Johnson syndrome: rare skin disorder with blistering and mucosal involvement.
• Hepatic dysfunction: abnormal liver enzyme elevations.
• Cardiac arrhythmia: uncommon but reported in isolated cases.

Before using Levocetirizin 1 A Pharma, consider the following safety measures.

• Renal impairment: dose may need adjustment in patients with reduced kidney function.
• Hepatic disease: monitor liver function tests periodically.
• Pregnancy: safety not established; discuss risks with a healthcare professional.
• Breastfeeding: assess benefit‑risk ratio before use.
• Elderly patients: start with the lowest effective dose and monitor for sedation.
• Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Levocetirizin may interact with other medicines that influence histamine pathways or central nervous system activity.

Major Interactions (Avoid)

• Ritonavir: can increase levocetirizine plasma levels, raising risk of adverse effects.
• Ketoconazole: may inhibit metabolism leading to higher exposure.

Moderate Interactions (Monitor Closely)

• Alcohol: may enhance drowsiness.
• CNS depressants (e.g., benzodiazepines): additive sedation possible.
• Other antihistamines: may increase anticholinergic burden.
• Theophylline: potential for reduced clearance of levocetirizine.
• Antacids containing aluminum or magnesium: may slightly decrease absorption.